relugolix, sold under the brand name relumina, is a gonadotropin-releasing hormone antagonist (gnrh antagonist) medication which is used in the treatment of uterine fibroids in japan. it is also under development for use in other countries and for the additional indications of endometriosis and prostate cancer. it is taken by mouth once per day.